Get startedLog in
    Picture of Evaxion A/S logo

    EVAX — Evaxion A/S News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Evaxion Biotech A/S reports results for the quarter ended December 31 - Earnings Summary

    Picture of Evaxion A/S logoEvaxion A/S
    01/04/2025 14:32
    Evaxion Biotech A/S EVAX.OQ reported a quarterly adjusted loss of 7 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-8.00.  The mean expectation of two analysts for the quarter was for a loss of $3.88 per share.

Revenue was $122.00 thousand​; analysts expected $1.66 million.

Evaxion Biotech A/S's reported EPS for the quarter was a loss of 7 cents​.

The company reported a quarterly loss of $3.63 million.

Evaxion Biotech A/S shares had held steady so far this quarter and lost 56.2% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 106.9% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Evaxion Biotech A/S is $44.88

This summary was machine generated from LSEG data April 1 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)


    QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
    Dec. 31 2024-3.88-0.07Beat
    Sep. 30 2024-1.43-0.20Beat
    Jun. 30 2024-1.95-0.60Beat
    Mar. 31 2024-2.771.50Beat

    Recent news on Evaxion A/S

    See all news